FDA Inspection 821895 — Hema Diagnostic Systems, L.L.C.

Hema Diagnostic Systems, L.L.C. — FEI 3003567343

The FDA completed an inspection of Hema Diagnostic Systems, L.L.C. on March 11, 2013 in Miramar, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 12 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 11, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Compliance: Devices
Location
Miramar, FL (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
313221 CFR 820.120Lack of or inadequate procedures for labeling
333121 CFR 820.181DMR - not or inadequately maintained
366921 CFR 820.20(c)Management review - defined interval, sufficient frequency
369621 CFR 820.100(b)Documentation
383721 CFR 820.25(b)Training records
44721 CFR 820.40Lack of procedures, or not maintained
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures